Physician profile
Warren Butt
NPI 1427129436
$1,926.24
in general payments reported to CMS, 2019-2025
18 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $48.86 · 2021: $153 · 2022: $153 · 2023: $180 · 2024: $508 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $659.64 | 2021-2025 | Skyrizi, Rinvoq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $500.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $120.00 | 2024 | |
| Medical Device Business Services, INC. | $120.00 | 2019 | |
| Pfizer INC. | $99.80 | 2019-2020 | |
| Celgene Corporation | $98.31 | 2023-2024 | Zeposia |
| Gilead Sciences, INC. | $57.73 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.71 | 2019-2020 | |
| Micro-Tech Endoscopy USA, INC. | $36.87 | 2024-2025 | Blueboost, Inflation Device |
| Janssen Biotech, INC. | $29.89 | 2022-2024 | Tremfya |
| Olympus America INC. | $29.18 | 2019 | |
| Daiichi Sankyo INC. | $24.34 | 2021 | |
| Axonics, INC. | $24.21 | 2022 | |
| Ardelyx, INC. | $23.16 | 2023 | Ibsrela |
| Ferring Pharmaceuticals INC. | $18.18 | 2023 | Rebyota |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $17.08 | 2019 | |
| Medtronic, INC. | $14.66 | 2023 | Gi Genius |
| Madrigal Pharmaceuticals | $14.48 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Butt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.